Carboxy Therapy Market Size, Share & Trend Analysis Report By Product Type (Table Top, Portable), By End-use (Hospitals, Aesthetic Clinics, Medspa), And Segment Forecasts, 2023 - 2030

Carboxy Therapy Market Growth & Trends

The global carboxy therapy market is expected to reach USD 83.05 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 11.9% from 2023 to 2030. The increasing adoption and awareness regarding non-invasive procedures are expected to boost the demand for carboxy therapy procedures globally. Carboxy therapy, also known as carbon dioxide therapy, is a non-surgical cosmetic procedure that involves the injection of carbon dioxide into the skin or subcutaneous tissue. The procedure is majorly used to treat various conditions, including cellulite, wrinkles, under-eye dark circles, and stretch marks.

Growing demand for non-surgical and minimally invasive cosmetic procedures, especially among the aging population, and increasing awareness of the advantages that can be offered through carboxy therapy for improving skin texture are the major driver of the market. In addition, advancements in technology, which have led to the development of new and improved carboxy therapy devices and techniques, and rising disposable incomes in developing countries that ultimately lead to increased spending on cosmetic treatments are some of the factors expected to boost the market growth. According to the International Society of Aesthetic Plastic Surgery Report 2021, the number of face and head surgical procedures is rising globally, increasing by around 14.8% from 2020 to 5,211,933 procedures globally. Moreover, face and head surgical procedures contribute to around 40.59% of the total surgical procedures. Thus, the market is expected to witness significant growth over the next few years.

Furthermore, the benefits offered by carboxy therapy including rejuvenation, effectiveness, and anti-aging properties are further expected to propel the growth of the market for carboxy therapy. Key players operating in the market are focusing on developing technologically advanced medical cosmetic products that may help in enhancing the adoption of carboxy therapy. For instance, in January 2020, Comopro announced the launch of the DIOX carboxytherapy system, an innovative system with added features including a touchscreen interface consisting of manual and automatic modes.

Carboxy Therapy Market Report Highlights

  • By product type, the table top segment held the largest share in 2022 and is expected to grow at a significant CAGR over the forecast period. This can be attributed to the higher availability of tabletop devices in aesthetic clinics
  • Based on the end-use, the aesthetic clinics segment held the dominant share in 2022 and is expected to witness a lucrative growth rate over the forecast period. This growth can be attributed to the growing preference for aesthetic clinics owing to their cost-effectiveness and availability of advanced and specialized treatment
  • North America dominated in 2022 with the largest share, owing to the rising geriatric population and growing preference for aesthetic surgeries and procedures
  • The market is highly fragmented, with the presence of many small players in the market. The players are adopting several strategies, including product launches, and technological advancement, to gain the competitive market share
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Objectives
1.3.1. Objective - 1
1.3.2. Objective - 2
1.3.3. Objective - 3
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR's Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.5.5. Details of Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Data Validation & Publishing
1.9. List of Abbreviations
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Carboxy Therapy Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools: Carboxy Therapy Market
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Covid-19 Impact Analysis
Chapter 4. Carboxy Therapy Market: Product Type Estimates & Trend Analysis
4.1. Carboxy Therapy Market, By Product Type: Key Takeaways
4.2. Carboxy Therapy Market: Product Type Movement & Market Share Analysis, 2022 & 2030
4.3. Table Top
4.3.1. Global Table Top Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Portable
4.4.1. Global Portable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Carboxy Therapy Market: End-Use Estimates & Trend Analysis
5.1. Carboxy Therapy Market, By End-Use: Key Takeaways
5.2. Carboxy Therapy Market: End-Use Movement & Market Share Analysis, 2022 & 2030
5.3. Hospital
5.3.1. Global Hospital Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Aesthetic Clinics
5.4.1. Global Aesthetic Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Medspa
5.5.1. Global Medspa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Carboxy Therapy Market: Regional Estimates & Trend Analysis
6.1. Carboxy Therapy Market: Regional Movement Analysis, 2022 & 2030
6.2. North America
6.2.1. North America Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. U.S. Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Canada Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. Key Country Dynamics
6.3.2.2. U.K. Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Germany Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. France Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Italy Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Spain Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Denmark Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Sweden Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Norway Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Japan Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. China Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. India Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Australia Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Thailand Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. South Korea Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Brazil Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Mexico Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Argentina Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. South Africa Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Saudi Arabia Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. UAE Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Kuwait Carboxy Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Carboxy Therapy Market: Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis, 2022
7.3. Strategy Mapping
7.4. Company Profiles/Listing
7.4.1. DTA Medical
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Cosmopro
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Carbossiterapia Italiana
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Mezopharma
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. MBE Medical Divisons
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Jontelaser Technologies Co., Ltd.
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Alvi Prague
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Kastner-Praxisbedarf
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. MEDAiON Plasma
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings